Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Sezary Syndrome 1Sarcoma, Synovial 1Ovarian Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Liposarcoma, Myxoid 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Merkel Cell 1Carcinoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

fludarabine 4Cyclophosphamide 4Interferon-gamma 2pembrolizumab 1interferon gamma-1b 1atezolizumab 1Trabectedin 1Radiation 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Liposarcoma, Myxoid × interferon gamma-1b × Clear all
NCT03063632 2023-10-25

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma

National Cancer Institute (NCI)

Phase 2 Completed
28 enrolled 15 charts
LymphoidSarcoma

Mycosis Fungoides, Sezary Syndrome, Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡